FDA Inspection 1039096 — Agnes Linglart, M.D., Ph.D.
The FDA completed an inspection of Agnes Linglart, M.D., Ph.D. on December 22, 2017 in Le Kremlin Bicetre Cedex. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 22, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Le Kremlin Bicetre Cedex (France)
Additional Details
Clinical Investigator (CI)